Back to search results

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Abroad (travel likely)RecruitingPHASE2

Conditions

Cytomegalovirus Infections · Primary Immune Deficiency Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Children's Hospital Los Angeles, Los Angeles, California, United States

    Contact: Study coordinator (Neena Kapoor, MD) · nkapoor@chla.usc.edu

  • University of California San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Julia Chu, MD) · Julia.Chu2@ucsf.edu

  • Indiana University, Indianapolis, Indiana, United States

    Contact: Study coordinator (Emily Hopewell, MD) · emlhope@iu.edu

  • Johns Hopkins, Baltimore, Maryland, United States

    Contact: Study coordinator (Kenneth Cooke, MD)

  • Washington University, St Louis, Missouri, United States

    Contact: Study coordinator (Shalini Shenoy, MD) · shalinishenoy@wustl.edu

  • New York Medical College, Valhalla, New York, United States

    Contact: Study coordinator (Mitchell S Cairo, MD) · mitchell_cairo@nymc.edu · 914-594-2150
    Contact: Principal Investigator (Mitchell S. Cairo, MD)

  • Nationwide Children's Hosptial, Columbus, Ohio, United States

    Contact: Study coordinator (Dean Lee, MD, PhD) · Dean.Lee@nationwidechildrens.org · 614-722-3550

  • Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Nancy Bunin, MD) · buninn@email.chop.edu · 215-590-2255

  • Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Julie A Talano, MD) · jtalano@mcw.edu · 414-955-4185
    Contact: Study coordinator (Meredith Beversdorf, RN) · mbeversdorf@mcw.edu · (414) 266-5891
Study leads

  • Mitchell S Cairo, MD

    Principal Investigator

    New York Medical College

View source on ClinicalTrials.gov(opens in a new tab)